{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T19:52:42Z","timestamp":1788292362883,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","meddos.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Dosimetry"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.meddos.2023.05.002","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T02:04:05Z","timestamp":1686881045000},"page":"238-244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Accelerated hypofractionated magnetic resonance-guided adaptive radiotherapy for oligoprogressive non-small cell lung cancer"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9814-2642","authenticated-orcid":false,"given":"Alonso","family":"La Rosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn E.","family":"Mittauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8328-7518","authenticated-orcid":false,"given":"Michael D.","family":"Chuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8768-3577","authenticated-orcid":false,"given":"Matthew D.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0416-8612","authenticated-orcid":false,"given":"Tugce","family":"Kutuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nema","family":"Bassiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6215-2427","authenticated-orcid":false,"given":"James","family":"McCulloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8215-4553","authenticated-orcid":false,"given":"Diane","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alonso N.","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjini","family":"Tolakanahalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minesh P.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupesh","family":"Kotecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.meddos.2023.05.002_bib0001","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.lungcan.2015.11.015","article-title":"The role of stereotactic ablative radiotherapy (SBRT) in the management of oligometastatic non small cell lung cancer","volume":"92","author":"Guerrero","year":"2016","journal-title":"Lung Cancer"},{"key":"10.1016\/j.meddos.2023.05.002_bib0002","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3389\/fonc.2019.01219","article-title":"Stereotactic body radiotherapy for oligometastatic disease in non-small cell lung cancer","volume":"9","author":"Wujanto","year":"2019","journal-title":"Frontiers in Oncology"},{"issue":"1","key":"10.1016\/j.meddos.2023.05.002_bib0003","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s13014-020-01651-y","article-title":"The value of local consolidative therapy in Osimertinib-treated non-small cell lung cancer with oligo-residual disease","volume":"15","author":"Zeng","year":"2020","journal-title":"Radiation Oncology"},{"key":"10.1016\/j.meddos.2023.05.002_bib0004","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.lungcan.2020.02.002","article-title":"ATOM: A phase II study to assess efficacy of preemptive local ablative therapy to residual oligometastases of NSCLC after EGFR TKI","volume":"142","author":"Chan","year":"2020","journal-title":"Lung Cancer"},{"issue":"1066","key":"10.1016\/j.meddos.2023.05.002_bib0005","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20160251","article-title":"Stereotactic body radiotherapy for oligoprogressive cancer","volume":"89","author":"Cheung","year":"2016","journal-title":"The British Journal of Radiology"},{"key":"10.1016\/j.meddos.2023.05.002_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.102894","article-title":"The use of radiation therapy for oligoprogressive\/oligopersistent oncogene-driven non small cell lung cancer: State of the art","volume":"148","author":"Franceschini","year":"2020","journal-title":"Critical Reviews in Oncology\/Hematology"},{"issue":"12","key":"10.1016\/j.meddos.2023.05.002_bib0007","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S1470-2045(16)30532-0","article-title":"Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study","volume":"17","author":"Gomez","year":"2016","journal-title":"Lancet Oncol"},{"issue":"18","key":"10.1016\/j.meddos.2023.05.002_bib0008","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.19.00201","article-title":"Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: Long-term results of a multi-institutional, phase II, randomized study","volume":"37","author":"Gomez","year":"2019","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.meddos.2023.05.002_bib0009","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.3501","article-title":"Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: A phase 2 randomized clinical trial","volume":"4","author":"Iyengar","year":"2018","journal-title":"JAMA Oncol"},{"issue":"8","key":"10.1016\/j.meddos.2023.05.002_bib0010","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1080\/0284186X.2021.1942545","article-title":"Ultra-central lung tumors: Safety and efficacy of protracted stereotactic body radiotherapy","volume":"60","author":"Lodeweges","year":"2021","journal-title":"Acta oncologica (Stockholm, Sweden)"},{"issue":"1","key":"10.1016\/j.meddos.2023.05.002_bib0011","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.lungcan.2015.04.014","article-title":"Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors","volume":"89","author":"Chaudhuri","year":"2015","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.meddos.2023.05.002_bib0012","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.prro.2015.09.012","article-title":"Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree","volume":"6","author":"Haseltine","year":"2016","journal-title":"Pract Radiat Oncol"},{"issue":"2","key":"10.1016\/j.meddos.2023.05.002_bib0013","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cllc.2011.03.007","article-title":"Phase I\/II trial of a COX-2 inhibitor with limited field radiation for intermediate prognosis patients who have locally advanced non-small-cell lung cancer: Radiation therapy oncology group 0213","volume":"12","author":"Gore","year":"2011","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.meddos.2023.05.002_bib0014","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1748-717X-7-33","article-title":"Accelerated hypofractionated radiation therapy compared to conventionally fractionated radiation therapy for the treatment of inoperable non-small cell lung cancer","volume":"7","author":"Amini","year":"2012","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.meddos.2023.05.002_bib0015","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijrobp.2015.05.004","article-title":"Precision hypofractionated radiation therapy in poor performing patients with non-small cell lung cancer: phase 1 dose escalation trial","volume":"93","author":"Westover","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.meddos.2023.05.002_bib0016","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-022-02070-x","article-title":"Magnetic resonance guided adaptive stereotactic body radiotherapy for lung tumors in ultracentral location: the MAGELLAN trial (ARO 2021-3)","volume":"17","author":"Regnery","year":"2022","journal-title":"Radiation oncology (London, England)"},{"issue":"10","key":"10.1016\/j.meddos.2023.05.002_bib0017","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1001\/jamaoncol.2021.3186","article-title":"Accelerated hypofractionated image-guided vs conventional radiotherapy for patients with stage II\/III non-small cell lung cancer and poor performance status: A randomized clinical trial","volume":"7","author":"Iyengar","year":"2021","journal-title":"JAMA Oncol"},{"issue":"5","key":"10.1016\/j.meddos.2023.05.002_bib0018","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7785\/tcrt.2012.500342","article-title":"The potential for an enhanced role for MRI in radiation-therapy treatment planning","volume":"12","author":"Metcalfe","year":"2013","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.meddos.2023.05.002_bib0019","series-title":"Imaging for Radiotherapy Planning. Grainger & Allison's Diagnostic Radiology","first-page":"1737","author":"Hoskin","year":"2021"},{"issue":"3","key":"10.1016\/j.meddos.2023.05.002_bib0020","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.meddos.2021.01.003","article-title":"Case report of visual biofeedback-driven, magnetic resonance-guided single-fraction SABR in breath hold for early stage non-small-cell lung cancer","volume":"46","author":"Chuong","year":"2021","journal-title":"Med Dosim"},{"key":"10.1016\/j.meddos.2023.05.002_bib0021","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejca.2019.07.021","article-title":"The transformation of radiation oncology using real-time magnetic resonance guidance: A review","volume":"122","author":"Hall","year":"2019","journal-title":"European Journal of Cancer"},{"issue":"4","key":"10.1016\/j.meddos.2023.05.002_bib0022","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.ijrobp.2018.05.048","article-title":"MR-guided Gated stereotactic radiation therapy delivery for lung, adrenal, and pancreatic tumors: A geometric analysis","volume":"102","author":"van S\u00f6rnsen de Koste","year":"2018","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"issue":"4","key":"10.1016\/j.meddos.2023.05.002_bib0023","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ijrobp.2016.08.006","article-title":"Magnetic resonance image guided radiation therapy for external beam accelerated partial-breast irradiation: evaluation of delivered dose and intrafractional cavity motion","volume":"96","author":"Acharya","year":"2016","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"issue":"5","key":"10.1016\/j.meddos.2023.05.002_bib0024","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.ijrobp.2021.09.014","article-title":"Consolidative Use of Radiotherapy to Block (CURB) Oligoprogression \u2015 Interim analysis of the first randomized study of stereotactic body radiotherapy in patients with oligoprogressive metastatic cancers of the lung and breast","volume":"111","author":"Tsai","year":"2021","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"10.1016\/j.meddos.2023.05.002_bib0025","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.radonc.2020.02.012","article-title":"Validation of an MR-guided online adaptive radiotherapy (MRgoART) program: Deformation accuracy in a heterogeneous, deformable, anthropomorphic phantom","volume":"146","author":"Mittauer","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.meddos.2023.05.002_bib0026","unstructured":"National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology. Non-small cell lung cancer. Version 5.2022. 2022. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/nscl.pdf."},{"issue":"2","key":"10.1016\/j.meddos.2023.05.002_bib0027","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijrobp.2009.09.042","article-title":"American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy","volume":"76","author":"Potters","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"30","key":"10.1016\/j.meddos.2023.05.002_bib0028","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2006.07.5937","article-title":"Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer","volume":"24","author":"Timmerman","year":"2006","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"12","key":"10.1016\/j.meddos.2023.05.002_bib0029","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1097\/JTO.0b013e31822e71d8","article-title":"Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer","volume":"6","author":"Haasbeek","year":"2011","journal-title":"Journal of Thoracic Oncology"},{"issue":"7","key":"10.1016\/j.meddos.2023.05.002_bib0030","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jtho.2016.03.008","article-title":"Outcomes of hypofractionated high-dose radiotherapy in poor-risk patients with \"ultracentral\" non-small cell lung cancer","volume":"11","author":"Tekatli","year":"2016","journal-title":"Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer"},{"issue":"11","key":"10.1016\/j.meddos.2023.05.002_bib0031","doi-asserted-by":"crossref","first-page":"S1835","DOI":"10.1016\/j.jtho.2017.09.525","article-title":"MA 09.02 Ultra-Central Tumors Treated with Stereotactic Body Radiotherapy: A Single Institutional Experience","volume":"12","author":"Yau","year":"2017","journal-title":"Journal of Thoracic oncology"},{"key":"10.1016\/j.meddos.2023.05.002_bib0032","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.lungcan.2020.07.009","article-title":"Analysis of pneumonitis and esophageal injury after stereotactic body radiation therapy for ultra-central lung tumors","volume":"147","author":"Wang","year":"2020","journal-title":"Lung Cancer"},{"issue":"7","key":"10.1016\/j.meddos.2023.05.002_bib0033","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jtho.2021.03.019","article-title":"The HILUS-trial-a prospective nordic multicenter phase 2 study of ultracentral lung tumors treated with stereotactic body radiotherapy","volume":"16","author":"Lindberg","year":"2021","journal-title":"Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer"},{"key":"10.1016\/j.meddos.2023.05.002_bib0034","doi-asserted-by":"crossref","DOI":"10.1177\/1533033819849073","article-title":"Impact of esophageal motion on dosimetry and toxicity with thoracic radiation therapy","volume":"18","author":"Gao","year":"2019","journal-title":"Technol Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.meddos.2023.05.002_bib0035","article-title":"Dose-escalated magnetic resonance image-guided abdominopelvic reirradiation with continuous intrafraction visualization, soft tissue tracking, and automatic beam gating","volume":"7","author":"Chuong","year":"2022","journal-title":"Adv Radiat Oncol"},{"issue":"2","key":"10.1016\/j.meddos.2023.05.002_bib0036","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.prro.2020.09.005","article-title":"Ablative 5-fraction stereotactic magnetic resonance-guided radiation therapy with on-table adaptive replanning and elective nodal irradiation for inoperable pancreas cancer","volume":"11","author":"Chuong","year":"2021","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.meddos.2023.05.002_bib0037","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.phro.2020.05.002","article-title":"Delivery of magnetic resonance-guided single-fraction stereotactic lung radiotherapy","volume":"14","author":"Finazzi","year":"2020","journal-title":"Phys Imaging Radiat Oncol"},{"issue":"4","key":"10.1016\/j.meddos.2023.05.002_bib0038","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.ijrobp.2019.03.035","article-title":"Role of on-table plan adaptation in MR-guided ablative radiation therapy for central lung tumors","volume":"104","author":"Finazzi","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Medical Dosimetry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095839472300047X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095839472300047X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:39:44Z","timestamp":1784806784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095839472300047X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"alternative-id":["S095839472300047X"],"URL":"https:\/\/doi.org\/10.1016\/j.meddos.2023.05.002","relation":{},"ISSN":["0958-3947"],"issn-type":[{"value":"0958-3947","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Accelerated hypofractionated magnetic resonance-guided adaptive radiotherapy for oligoprogressive non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Medical Dosimetry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meddos.2023.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}